(Q53641313)

16 May 2018

title

MiR-214 regulates the pathogenesis of patients with coronary artery disease by targeting VEGF. (English)

1 reference

16 May 2018

main subject

coronary artery disease

1 reference

Yan Jin

1

1 reference

16 May 2018

Cheng-Jian Yang

2

1 reference

16 May 2018

Xin Xu

3

1 reference

16 May 2018

Jia-Ning Cao

4

1 reference

16 May 2018

Qiu-Ting Feng

5

1 reference

16 May 2018

Jun Yang

6

1 reference

16 May 2018

publication date

10 January 2015

1 reference

16 May 2018

Molecular and Cellular Biochemistry

published in

1 reference

16 May 2018

volume

402

1 reference

16 May 2018

issue

1-2

1 reference

16 May 2018

page(s)

111-122

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1007/s11010-014-2319-5

exact match

0 references

cites work

Deficiency of the microRNA-31-microRNA-720 pathway in the plasma and endothelial progenitor cells from patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Controlled type II diabetes mellitus has no major influence on platelet micro-RNA expression. Results from micro-array profiling in a cohort of 60 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Diagnostic potential of plasmatic MicroRNA signatures in stable and unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Small RNA overcomes the challenges of therapeutic targeting of microsomal triglyceride transfer protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Decreased expression of miR-133a but not of miR-1 is associated with signs of heart failure in patients undergoing coronary bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Elevation of miR-221 and -222 in the internal mammary arteries of diabetic subjects and normalization with metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Increased expression of microRNA-221 inhibits PAK1 in endothelial progenitor cells and impairs its function via c-Raf/MEK/ERK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Bone morphogenetic protein-2 decreases microRNA-30b and microRNA-30c to promote vascular smooth muscle cell calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Regulation of microRNA-155 in atherosclerotic inflammatory responses by targeting MAP3K10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Integrative proteomic and microRNA analysis of primary human coronary artery endothelial cells exposed to low-dose gamma radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Comprehensive exploration of the effects of miRNA SNPs on monocyte gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Decreased miR-181a expression in monocytes of obese patients is associated with the occurrence of metabolic syndrome and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

MicroRNAs in aortic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2319-5

MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes

21 January 2018

1 reference

12 December 2020

Endothelial Microparticle–Mediated Transfer of MicroRNA-126 Promotes Vascular Endothelial Cell Repair via SPRED1 and Is Abrogated in Glucose-Damaged Endothelial Microparticles

1 reference

12 December 2020

Microvesicle-associated microRNA expression is altered upon particulate matter exposure in healthy workers and in A549 cells

1 reference

12 December 2020

Circulating microRNAs (miR-423-5p, miR-208a and miR-1) in acute myocardial infarction and stable coronary heart disease

1 reference

12 December 2020

Circulating miR-214 is associated with the severity of coronary artery disease

1 reference

12 December 2020

Tissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm

1 reference

12 December 2020

10.1007/S11010-014-2319-5

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018